Defective protein trafficking of HERG K+ channels in human congenital long QT syndrome

Craig T. January, Qiuming Gong, Zhengfeng Zhou

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

It is now clear that LQT2 represents a large number of mutations throughout the HERG channel protein that cause a decrease in IKr amplitude to increase in the QT interval. At least for LQT2, this is a disease of increasing complexity that depends on many mechanisms involving abnormalities in HERG protein processing and trafficking, HERG channel function and subunit co-assembly that vary from one mutation to the next. In a simplified form this is shown in Figure 5. For many LQT2 mutations, the dominant mechanism appears to be retention and degradation of abnormal protein in the endoplasmic reticulum and its failure to traffic to the plasma, even if the channel is capable of functioning biophysically. Thus, in patients the emerging data support the concept that it is the interaction of several mechanisms that determines IKr properties, and contributes to the variable expression and severity of the LQT2 phenotype. As our understanding of these mechanisms and their interactions increases, this offers the potential for new therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)27-34
Number of pages8
JournalPharmaceutical News
Volume7
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Long QT Syndrome
Protein Transport
Mutation
Endoplasmic Reticulum
Proteolysis
Phenotype
Proteins
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Defective protein trafficking of HERG K+ channels in human congenital long QT syndrome. / January, Craig T.; Gong, Qiuming; Zhou, Zhengfeng.

In: Pharmaceutical News, Vol. 7, No. 4, 2000, p. 27-34.

Research output: Contribution to journalArticle

@article{d676626c37854eeb88520b91e12c2c2b,
title = "Defective protein trafficking of HERG K+ channels in human congenital long QT syndrome",
abstract = "It is now clear that LQT2 represents a large number of mutations throughout the HERG channel protein that cause a decrease in IKr amplitude to increase in the QT interval. At least for LQT2, this is a disease of increasing complexity that depends on many mechanisms involving abnormalities in HERG protein processing and trafficking, HERG channel function and subunit co-assembly that vary from one mutation to the next. In a simplified form this is shown in Figure 5. For many LQT2 mutations, the dominant mechanism appears to be retention and degradation of abnormal protein in the endoplasmic reticulum and its failure to traffic to the plasma, even if the channel is capable of functioning biophysically. Thus, in patients the emerging data support the concept that it is the interaction of several mechanisms that determines IKr properties, and contributes to the variable expression and severity of the LQT2 phenotype. As our understanding of these mechanisms and their interactions increases, this offers the potential for new therapeutic approaches.",
author = "January, {Craig T.} and Qiuming Gong and Zhengfeng Zhou",
year = "2000",
language = "English (US)",
volume = "7",
pages = "27--34",
journal = "Pharmaceutical News",
issn = "1071-894X",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Defective protein trafficking of HERG K+ channels in human congenital long QT syndrome

AU - January, Craig T.

AU - Gong, Qiuming

AU - Zhou, Zhengfeng

PY - 2000

Y1 - 2000

N2 - It is now clear that LQT2 represents a large number of mutations throughout the HERG channel protein that cause a decrease in IKr amplitude to increase in the QT interval. At least for LQT2, this is a disease of increasing complexity that depends on many mechanisms involving abnormalities in HERG protein processing and trafficking, HERG channel function and subunit co-assembly that vary from one mutation to the next. In a simplified form this is shown in Figure 5. For many LQT2 mutations, the dominant mechanism appears to be retention and degradation of abnormal protein in the endoplasmic reticulum and its failure to traffic to the plasma, even if the channel is capable of functioning biophysically. Thus, in patients the emerging data support the concept that it is the interaction of several mechanisms that determines IKr properties, and contributes to the variable expression and severity of the LQT2 phenotype. As our understanding of these mechanisms and their interactions increases, this offers the potential for new therapeutic approaches.

AB - It is now clear that LQT2 represents a large number of mutations throughout the HERG channel protein that cause a decrease in IKr amplitude to increase in the QT interval. At least for LQT2, this is a disease of increasing complexity that depends on many mechanisms involving abnormalities in HERG protein processing and trafficking, HERG channel function and subunit co-assembly that vary from one mutation to the next. In a simplified form this is shown in Figure 5. For many LQT2 mutations, the dominant mechanism appears to be retention and degradation of abnormal protein in the endoplasmic reticulum and its failure to traffic to the plasma, even if the channel is capable of functioning biophysically. Thus, in patients the emerging data support the concept that it is the interaction of several mechanisms that determines IKr properties, and contributes to the variable expression and severity of the LQT2 phenotype. As our understanding of these mechanisms and their interactions increases, this offers the potential for new therapeutic approaches.

UR - http://www.scopus.com/inward/record.url?scp=0034588584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034588584&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 27

EP - 34

JO - Pharmaceutical News

JF - Pharmaceutical News

SN - 1071-894X

IS - 4

ER -